CN Stock MarketDetailed Quotes

Yabao Pharmaceutical Group (600351)

Watchlist
  • 6.95
  • -0.01-0.14%
Pre-Opening Auction May 12 09:30 CST
4.81BMarket Cap15.04P/E (TTM)

Yabao Pharmaceutical Group (600351) Key Financial Indicators

600351 Earnings per Share (EPS)

According to the latest financial report of Yabao Pharmaceutical Group, the latest earnings per share (TTM) for the company is 0.15. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CNY

Cumulative Quarterly

Loading...

600351 Book Value Per Share (BVPS)

Analyzing a company's fundamentals? Check out Yabao Pharmaceutical Group's latest financial report to see how much their book value per share (BVPS) is currently at 4.12.

Currency: CNY

Cumulative Quarterly

Loading...

600351 Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Yabao Pharmaceutical Group shows that the company's current ratio is 3.92, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

Loading...

600351 Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Yabao Pharmaceutical Group, the quick ratio is 3.20, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

Loading...

600351 Return on Equity (ROE)

Want to learn more about the financial health of Yabao Pharmaceutical Group? The latest ROE figure is 3.72%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

Loading...

600351 Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Yabao Pharmaceutical Group, the total asset return on investment (ROA) is 3.26%.

Currency: CNY

Cumulative Quarterly

Loading...

600351 Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Yabao Pharmaceutical Group's latest financial report to see how their gross margin is doing - currently at 53.24%.

Currency: CNY

Cumulative Quarterly

Loading...

600351 Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Yabao Pharmaceutical Group, the net profit margin is 18.70%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

Loading...

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting an immediate response from Iran: no one Show More